Tramadol: Drug Safety Communication - FDA Evaluating Risks of Using in Children Aged 17 and Younger

Ultra-rapid metabolizers are more likely to have higher-than-normal amounts of the active form of the opioid in their blood after taking tramadol, which can result in breathing difficulty that may lead to death.

 
comments powered by Disqus